Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Increased Drug Outsourcing To China, India A Concern In U.S.

This article was originally published in PharmAsia News

Executive Summary

America's increasing reliance on drugs produced in other countries, primarily China and India, is causing concern among U.S. lawmakers and some health experts. They note that no antibiotics are being made in the United States any more and the active pharmaceutical ingredients for dozens of other vital drugs also come from those two countries. U.S. FDA records show that of 1,154 production plants listed in generics applications, 43 percent were in China, 39 percent in India. Sen. Sherrod Brown, D-Ohio, cited a lack of regulations covering outsourcing as a problem at a time of concern about bioterrorism and counterfeits. (Click here for more
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC069882

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel